Protease- and antibody-directed PA conjugates provide dual-targeting
selectivity. (A) Cartoon illustrations of IgG-mPAC conjugates cleaved
by proteases uPA and MMP-9. (B) SDS-PAGE gel analysis with Western
blot visualization of the protease-treated conjugates: Cmab-mPAC,
Cmab-mPAC-uPA (Cmab-uPA), and Cmab-mPAC-MMP (Cmab-MMP). (C–F)
Relative viability of EGFR-positive cells expressing the uPA and MMP
proteases (MDA-MB-231, BT549) after incubation with or without 10
nM LFN-DTA, and with 10-fold serial dilutions of (C, D)
Cmab-mPAC-uPA or (E, F) Cmab-mPAC-MMP. Cell viability was determined
by the relative luminescence from a CellTiter-Glo assay, which was
normalized to untreated cells. Data represent the mean ± s.d.
of three replicate wells.